Magnesium Sulfate Injection, Solution
Product Images NDC 72572-511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Magnesium Sulfate (NDC 72572-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Magnesium Sulfate In Water Representative Container Label 72572-511-40 (Image 01)

Magnesium Sulfate In Water Representative Container Label 72572-511-40 (Image 01)
This is a description of a medication labeled as NDC 72672-511-40. It is a single-dose container of Magnesium Sulfate solution for intravenous infusion. Each 50 mL contains 2g of Magnesium Sulfate Heptahydrate equivalent to 16.25 mEq of magnesium. The solution may contain sulfuric acid and/or sodium hydroxide for pH adjustment. It is recommended to discard any unused portion and to only use clear and undamaged containers. The solution should be stored at 20 to 26°C (68 to 77°F) and protected from freezing. The container is specified not to contain natural rubber latex, DEHP, or PVC. The medication is distributed by Civica, Inc. located in Lehi, Utah, and manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA.*
FDA Label Image

Magnesium Sulfate In Water Representative Overpouch Label 72572-511-40 (Image 02)

Magnesium Sulfate In Water Representative Overpouch Label 72572-511-40 (Image 02)
The text provides details about a medication called Magnesium Sulfate in Water for Injection, administered via intravenous infusion. Each 50 mL container contains 2 g of Magnesium Sulfate, equivalent to 16.25 mEq magnesium. Instructions include discarding unused portions, not adding supplementary medication, and using the central route whenever possible. It emphasizes checking for leaks before use and storing the solution at 20-25°C (68-77°F). The medication should be used promptly once the overwrap is removed. The container is single-use and must not be used in series connections. The product is distributed by Civica, Inc. with manufacturing information listed for Baxter Healthcare Corporation and being made in Spain.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.